US8492389B2
(en)
|
2000-04-25 |
2013-07-23 |
Icos Corporation |
Inhibitors of human phosphatidylinositol 3-kinase delta
|
US10010550B2
(en)
|
2000-04-25 |
2018-07-03 |
Icos Corporation |
Inhibitors of human phosphatidylinositol 3-kinase delta
|
US8623881B2
(en)
|
2000-04-25 |
2014-01-07 |
Icos Corporation |
Inhibitors of human phosphatidylinositol 3-kinase delta
|
US6949535B2
(en)
|
2000-04-25 |
2005-09-27 |
Icos Corporation |
Inhibitors of human phosphatidyl-inositol 3-kinase delta
|
US10695349B2
(en)
|
2000-04-25 |
2020-06-30 |
Icos Corporation |
Inhibitors of human phosphatidylinositol 3-kinase delta
|
US8138195B2
(en)
|
2000-04-25 |
2012-03-20 |
Icos Corporation |
Inhibitors of human phosphatidylinositol 3-kinase delta
|
US6667300B2
(en)
|
2000-04-25 |
2003-12-23 |
Icos Corporation |
Inhibitors of human phosphatidylinositol 3-kinase delta
|
US10398695B2
(en)
|
2000-04-25 |
2019-09-03 |
Icos Corporation |
Inhibitors of human phosphatidylinositol 3-kinase delta
|
US8653077B2
(en)
|
2000-04-25 |
2014-02-18 |
Icos Corporation |
Inhibitors of human phosphatidylinositol 3-kinase delta
|
US8637533B2
(en)
|
2000-04-25 |
2014-01-28 |
Icos Corporation |
Inhibitors of human phosphatidylinositol 3-kinase delta
|
US9487772B2
(en)
|
2000-04-25 |
2016-11-08 |
Icos Corporation |
Inhibitors of human phosphatidylinositol 3-kinase delta
|
AU2001255667C1
(en)
*
|
2000-04-25 |
2016-06-09 |
Icos Corporation |
Inhibitors of human phosphatidyl-inositol 3-kinase delta
|
WO2003035075A1
(en)
*
|
2001-10-19 |
2003-05-01 |
Icos Corporation |
Inhibitors of human phosphatidyl-inositol 3-kinase delta
|
JP4945060B2
(ja)
*
|
2001-10-19 |
2012-06-06 |
イコス・コーポレイション |
人間のホスファチジルイノシトール3−キナーゼデルタの阻害
|
JP2005509635A
(ja)
*
|
2001-10-19 |
2005-04-14 |
アイコス コーポレイション |
人間のホスファチジルイノシトール3−キナーゼデルタの阻害
|
US8779131B2
(en)
|
2004-05-13 |
2014-07-15 |
Icos Corporation |
6-fluoro-3-phenyl-2-[1-(9H-purin-6-ylamino)-ethyl]-3H-quinazolin-4-one as an inhibitor of human phosphatidylinositol 3-kinase delta
|
US8586597B2
(en)
|
2004-05-13 |
2013-11-19 |
Icos Corporation |
6-fluoro-3-phenyl-2-[1-(9H-purin-6-ylamino)ethyl]-3H-quinazolin-4-one as an inhibitor of human phosphatidylinositol 3-kinase delta
|
US7932260B2
(en)
|
2004-05-13 |
2011-04-26 |
Icos Corporation |
Quinazolinones as inhibitors of human phosphatidylinositol 3-kinase delta
|
US9149477B2
(en)
|
2004-05-13 |
2015-10-06 |
Icos Corporation |
5-fluoro-3-phenyl-2-[1-(9h-purin-6-ylamino)propyl]-3h-quinazolin-4-one as an inhibitor of human phosphatidylinositol 3-kinase delta
|
USRE44599E1
(en)
|
2004-05-13 |
2013-11-12 |
Icos Corporation |
Quinazolinones as inhibitors of human phosphatidylinositol 3-kinase delta
|
US8207153B2
(en)
|
2004-05-13 |
2012-06-26 |
Icos Corporation |
Quinazolinones as inhibitors of human phosphatidylinositol 3-kinase delta
|
US10906907B2
(en)
|
2004-05-13 |
2021-02-02 |
Icos Corporation |
Tert-butyl (s)-(1-(5-fluoro-4-oxo-3-phenyl-3,4-dihydroquinazolin-2-yl)propyl)carbamate precursor of a quinazolinone inhibitor of human phosphatidylinositol 3-kinase delta and a process for preparing thereof
|
USRE44638E1
(en)
|
2004-05-13 |
2013-12-10 |
Icos Corporation |
Quinazolinones as inhibitors of human phosphatidylinositol 3-kinase delta
|
US10336756B2
(en)
|
2004-05-13 |
2019-07-02 |
Icos Corporation |
(S)-2-(1-aminopropyl)-5-fluoro-3-phenylquinazolin-4(3H)-one precursor of a quinazolinone as inhibitor of human phosphatidylinositol 3-kinase delta
|
US10154998B2
(en)
|
2008-11-13 |
2018-12-18 |
Gilead Calistoga Llc |
Therapies for hematologic malignancies
|
US8440677B2
(en)
|
2009-03-24 |
2013-05-14 |
Gilead Calistoga Llc |
Atropisomers of 2-purinyl-3-tolyl-quinazolinone derivatives and methods of use
|
US8546409B2
(en)
|
2009-04-20 |
2013-10-01 |
Gilead Calistoga Llc |
Methods of treatment for solid tumors
|
US8691829B2
(en)
|
2009-07-21 |
2014-04-08 |
Gilead Calistoga Llc |
Treatment of liver disorders with PI3K inhibitors
|
US8865730B2
(en)
|
2012-03-05 |
2014-10-21 |
Gilead Calistoga Llc |
Polymorphic forms of (S)-2-(1-(9H-purin-6-ylamino)propyl)-5-fluoro-3-phenylquinazolin-4(3H)-one
|
US10730879B2
(en)
|
2012-03-05 |
2020-08-04 |
Gilead Calistoga Llc |
Polymorphic forms of (S)-2-(1-(9H-purin-6-ylamino)propyl)-5-fluoro-3-phenylquinazolin-4(3H)-one
|
US9469643B2
(en)
|
2012-03-05 |
2016-10-18 |
Gilead Calistoga, LLC. |
Polymorphic forms of (S)-2-(1-(9H-purin-6-ylamino)propyl)-5-fluoro-3-phenylquinazolin-4(3H)-one
|
US10047060B2
(en)
|
2013-12-20 |
2018-08-14 |
Gilead Calistoga Llc |
Process methods for phosphatidylinositol 3-kinase inhibitors
|
US10442805B2
(en)
|
2013-12-20 |
2019-10-15 |
Gilead Calistoga Llc |
Polymorphic forms of a hydrochloride salt of (S)-2-(1-(9H-purin-6-ylamino)propyl)-5-fluoro-3-phenylquinazolin-4(3H)-one
|
US10414737B2
(en)
|
2013-12-20 |
2019-09-17 |
Gilead Sciences, Inc. |
Process methods for phosphatidylinositol 3-kinase inhibitors
|
US10059677B2
(en)
|
2013-12-20 |
2018-08-28 |
Gilead Calistoga Llc |
Process for preparing phosphatidylinositol 3-kinase inhibitors and intermediates thereof
|
US9708327B2
(en)
|
2013-12-20 |
2017-07-18 |
Gilead Calistoga Llc |
Polymorphic forms of a hydrochloride salt of (S)-2-(1-(9H-purin-6-ylamino)propyl)-5-fluoro-3-phenylquinazolin-4(3H)-one
|
US10954199B2
(en)
|
2013-12-20 |
2021-03-23 |
Gilead Sciences, Inc. |
Process methods for phosphatidylinositol 3-kinase inhibitors
|
US11021467B2
(en)
|
2014-06-13 |
2021-06-01 |
Gilead Sciences, Inc. |
Phosphatidylinositol 3-kinase inhibitors
|